Discovery of placental microRNAs associated with maternal insulin sensitivity during pregnancy
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- American Diabetes Association Research Foundation (1-15-ACE-26)
- Quebec Health Research Fund (20697)
- Canadian Institutes of Health Research (K23 DK113218)
- Canadian Institutes of Health Research (PJT-152989)
- Canadian Institutes of Health Research (MOP 115071)
- Canadian Institutes of Health Research (-152989)
- Canadian Institutes of Health Research (115071)
- National Institutes of Health (R01HD094150)
- American Diabetes Association
- Diabetes Quebec
This publication has 73 references indexed in Scilit:
- Expression and clinical significance of miR-141-5p as a biomarker in the serum of patients with early spontaneous abortionClinics, 2024
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen DepositionCell Reports, 2019
- exceRpt: A Comprehensive Analytic Platform for Extracellular RNA ProfilingCell Systems, 2019
- Elevated microRNA-141-3p in placenta of non-diabetic macrosomia regulate trophoblast proliferationEBioMedicine, 2018
- MicroRNAs in placental health and diseaseAmerican Journal of Obstetrics and Gynecology, 2015
- Angiogenesis in diabetes and obesityReviews in Endocrine and Metabolic Disorders, 2015
- MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretionBiochemical and Biophysical Research Communications, 2012
- Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetesDiabetologia, 2010
- Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnanciesAmerican Journal of Obstetrics and Gynecology, 2009